HCID 67096124, compound → HCID 57780724, compound

HRID 2076090Notes

Reaction equation

[C:1]([CH:5]1[CH2:10][CH2:9][CH2:8]/[C:7](=[CH:11]\N(C)C)/[C:6]1=O)([CH3:4])([CH3:3])[CH3:2].[N+]([O-])(O)=O.[N+]([O-])(O)=O.[CH3:24][O:25][C:26]1[CH:27]=[C:28]([NH:38][C:39]([NH2:41])=[NH:40])[CH:29]=[CH:30][C:31]=1[N:32]1[CH:36]=[C:35]([CH3:37])[N:34]=[CH:33]1>>[C:1]([CH:5]1[C:6]2[N:41]=[C:39]([NH:38][C:28]3[CH:29]=[CH:30][C:31]([N:32]4[CH:36]=[C:35]([CH3:37])[N:34]=[CH:33]4)=[C:26]([O:25][CH3:24])[CH:27]=3)[N:40]=[CH:11][C:7]=2[CH2:8][CH2:9][CH2:10]1)([CH3:4])([CH3:3])[CH3:2]

Participants

Reactant 2

HCID 67096124HCID 67096124, compound

HCID 178493228HCID 178493228, compound

Product 1

HCID 57780724HCID 57780724, compound

Procedure

The title compound was prepared from crude 2-tert-butyl-6-[1-dimethylamino-meth-(E)-ylidene]-cyclohexanone (100 mg, 0.48 mmol) and N-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-guanidine dinitrate (111 mg, 0.30 mmol) using in analogous manner the procedure described in example 45b). Obtained as a yellow solid (59 mg, 50%). MS ISP (m/e): 392.3 (100) [(M+H)+]. 1H NMR (DMSO-D6, 300 MHz): δ (ppm)=9.43 (s, 1H), 8.22 (s, 1H), 7.76 (s, 1H), 7.64 (s, 1H), 7.43 (d, 1H), 7.19 (d, 1H), 7.02 (s, 1H), 3.78 (s, 3H), 2.51-2.65 (m, 2H), 2.14 (s, 3H), 1.91 (m, 2H), 1.73 (m, 1H), 1.40 (m, 1H), 1.03 (s, 9H).

Sources & evidence

ORD record: ord-6d54ceb10f3046c4928297dacf8c7c25
Source dataset: uspto-grants-2011_04
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07923450B2

Reaction notes

Loading…